USPTO serial 87488880
GENTLE WARRIORS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 26, 2019
- Examiner
- DESAI, BRIN ANDERSON
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 704 applies to Madrid Protocol extensions of protection in the U.S. Section 71 (similar to Section 8) showing continued use was accepted. The U.S. extension remains active. Follow Madrid and USPTO deadlines for the next renewal cycle.
Need help with GENTLE WARRIORS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Purapharm International (H.K.) Limited
Central, HK
Other trademarks owned by Purapharm International (H.K.) Limited
Purapharm International (H.K.) Limited
Central, HK
Other trademarks owned by Purapharm International (H.K.) Limited
Purapharm International (H.K.) Limited
Tai Po, NT, HK
Other trademarks owned by Purapharm International (H.K.) Limited
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Haverly MacArthur
Haverly MacArthur ADAMS AND REESE LLP1600 West End AvenueSuite 1400Nashville, TN 37203Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Health preparations for medical purposes for strengthening the immune system and restoring normal bodily functions, the treatment, mitigation and prevention of diseases and disorders, namely, digestive diseases and disorders, central nervous system diseases and disorders, namely, brain diseases, movement disorders, ocular motility, respiratory diseases and disorders, excretory diseases and disorders, cardiovascular diseases and disorders, reproductive diseases and disorders, endocrinal diseases and disorders, immunological diseases and disorders, namely, autoimmune diseases, immunologic deficiency syndrome, hepatitis, dermatological diseases and disorders, skeletal diseases and disorders, namely, bone diseases, back pain, muscular diseases and disorders, namely, muscular dystrophy, inflammatory muscle diseases, sensory diseases and disorders, namely, blindness; medicines for human purposes for strengthening the immune system and restoring normal bodily functions, the treatment, mitigation and prevention of diseases and disorders, namely, digestive diseases and disorders, central nervous system diseases and disorders, namely, brain diseases, movement disorders, ocular motility, respiratory diseases and disorders, excretory diseases and disorders, cardiovascular diseases and disorders, reproductive diseases and disorders, endocrinal diseases and disorders, immunological diseases and disorders, namely, autoimmune diseases, immunologic deficiency syndrome, hepatitis, dermatological diseases and disorders, skeletal diseases and disorders, namely, bone diseases, back pain, muscular diseases and disorders, namely, muscular dystrophy, inflammatory muscle diseases, sensory diseases and disorders, namely, blindness; [ medicines for veterinary purposes for strengthening the immune system and restoring normal bodily functions, the treatment, mitigation and prevention of diseases and disorders, namely, digestive diseases and disorders, central nervous system diseases and disorders, namely, brain diseases, movement disorders, ocular motility, respiratory diseases and disorders, excretory diseases and disorders, cardiovascular diseases and disorders, reproductive diseases and disorders, endocrinal diseases and disorders, immunological diseases and disorders, namely, autoimmune diseases, immunologic deficiency syndrome, hepatitis, dermatological diseases and disorders, skeletal diseases and disorders, namely, bone diseases, back pain, muscular diseases and disorders, namely, muscular dystrophy, inflammatory muscle diseases, sensory diseases and disorders, namely, blindness; medicines for dental purposes; ] medicinal herbs; medicines, including Chinese medicines and Chinese patent medicines, for strengthening the immune system and restoring normal bodily functions, the treatment, mitigation and prevention of diseases and disorders, namely, digestive diseases and disorders, central nervous system diseases and disorders, namely, brain diseases, movement disorders, ocular motility, respiratory diseases and disorders, excretory diseases and disorders, cardiovascular diseases and disorders, reproductive diseases and disorders, endocrinal diseases and disorders, immunological diseases and disorders, namely, autoimmune diseases, immunologic deficiency syndrome, hepatitis, dermatological diseases and disorders, skeletal diseases and disorders, namely, bone diseases, back pain, muscular diseases and disorders, namely, muscular dystrophy, inflammatory muscle diseases, sensory diseases and disorders, namely, blindness; medical infusions, namely, medicinal herbal infusions; herbal food supplements adapted for medical use; herbal food supplements; pharmaceuticals [ , ] and medical [ and veterinary ] preparations for strengthening the immune system and restoring normal bodily functions, the treatment, mitigation and prevention of diseases and disorders, namely, digestive diseases and disorders, central nervous system diseases and disorders, namely, brain diseases, movement disorders, ocular motility, respiratory diseases and disorders, excretory diseases and disorders, cardiovascular diseases and disorders, reproductive diseases and disorders, endocrinal diseases and disorders, immunological diseases and disorders, namely, autoimmune diseases, immunologic deficiency syndrome, hepatitis, dermatological diseases and disorders, skeletal diseases and disorders, namely, bone diseases, back pain, muscular diseases and disorders, namely, muscular dystrophy, inflammatory muscle diseases, sensory diseases and disorders, namely, blindness [ ; sanitary preparations for medical purposes ] ; dietetic food and substances adapted for medical [ or veterinary ] use [ , food for babies ] ; dietary supplements for humans [ and animals; plasters for medical purposes; materials for medical dressings, namely, gauze and bandages; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides ] | ACTIVE | — |
| 030 | Processed herbs; herbal infusions, not adapted for medical use [ ; tea-based beverages; coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour; preparations made from cereals, namely, cereal-based snack foods and cereal bars; bread, pastries and confectionery in the nature of confectionery made of sugar; edible ices; sugar, honey, treacle; yeast, baking-powder; salt; mustard; vinegar, sauces; spices; ice ] | ACTIVE | — |
| 032 | [ Non-alcoholic beverages, namely, non-alcoholic beverages with tea flavor; preparations for making beverages, namely, fruit drinks and non-alcoholic beverages; ] essences for making beverages not in the nature of essential oils, namely, essences for making [ soft drinks and ] non-alcoholic beverages [ ; beers; mineral and aerated waters; fruit-based beverages and fruit juices; syrups for making tea ] | ACTIVE | — |
| 035 | [ Mediation of agreements for the purchase and sale of health preparations for medical purposes, medicines for human purposes, medicines for veterinary purposes, medicines for dental purposes, medicinal herbs, medicines, including Chinese medicines and Chinese patent medicines, herbal food supplements, both for medical and non-medical use, herbs, and infusions for both medical and non-medical use, including those in the context of wholesaling; retail store services in the field of herbs and herb-related goods; retail and wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; online and physical shop retail and wholesale store services in the field of health preparations for medical purposes; advertising; business management; business administration; office functions ] | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Purapharm International (H.K.) Limited
- Other trademarks owned by Purapharm International (H.K.) Limited
- Other trademarks owned by Purapharm International (H.K.) Limited
- Other trademarks in Class 005
- Other trademarks in Class 030
- Other trademarks in Class 032
- Other trademarks in Class 035
- Similar marks named GENTLE WARRIORS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 23, 2025 | NAS8 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED | — |
| Jun 23, 2025 | 8.PR | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED | — |
| Jun 10, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Feb 26, 2025 | ES8R | TEAS SECTION 8 RECEIVED | — |
| Feb 26, 2024 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jan 4, 2022 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jan 4, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 4, 2022 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Jan 4, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 4, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 4, 2022 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Feb 26, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 11, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 11, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 21, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 16, 2018 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Oct 4, 2018 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Sep 29, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 19, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 19, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 18, 2018 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Jul 5, 2018 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Jul 5, 2018 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Jul 5, 2018 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Jan 2, 2018 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jan 2, 2018 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jan 2, 2018 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Dec 11, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 11, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 7, 2017 | ALIE | ASSIGNED TO LIE | — |
| Nov 29, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 17, 2017 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Aug 17, 2017 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Aug 17, 2017 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Aug 9, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 22, 2017 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Jun 21, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 17, 2017 | NWAP | NEW APPLICATION ENTERED | — |